Parkinson disease: Serotonin reuptake inhibitors for depression in PD

Autores
Pérez Lloret, Santiago; Rascol, Olivier
Año de publicación
2012
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that these drugs are beneficial for the treatment of depressive disorders in Parkinson disease. Whether these treatments will offer such benefits in the long term compared with other pharmacological and nonpharmacological approaches remains to be determined.
Fil: Pérez Lloret, Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Toulouse; Francia
Fil: Rascol, Olivier. University of Toulouse; Francia
Materia
enfermedad de parkinson
antidepresivos
depresión
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/96182
Acceder
id CONICETDig_f7e66f864f846eacd604c1bcb838273c
oai_identifier_str oai:ri.conicet.gov.ar:11336/96182
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Parkinson disease: Serotonin reuptake inhibitors for depression in PDPérez Lloret, SantiagoRascol, Olivierenfermedad de parkinsonantidepresivosdepresiónhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that these drugs are beneficial for the treatment of depressive disorders in Parkinson disease. Whether these treatments will offer such benefits in the long term compared with other pharmacological and nonpharmacological approaches remains to be determined.Fil: Pérez Lloret, Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Toulouse; FranciaFil: Rascol, Olivier. University of Toulouse; FranciaNature Publishing Group2012-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/96182Pérez Lloret, Santiago; Rascol, Olivier; Parkinson disease: Serotonin reuptake inhibitors for depression in PD; Nature Publishing Group; Nature Reviews Neurology; 8; 7; 7-2012; 365-3661759-4758CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/nrneurol.2012.111info:eu-repo/semantics/altIdentifier/doi/10.1038/nrneurol.2012.111info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:56:49Zoai:ri.conicet.gov.ar:11336/96182instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:56:49.859CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Parkinson disease: Serotonin reuptake inhibitors for depression in PD
title Parkinson disease: Serotonin reuptake inhibitors for depression in PD
spellingShingle Parkinson disease: Serotonin reuptake inhibitors for depression in PD
Pérez Lloret, Santiago
enfermedad de parkinson
antidepresivos
depresión
title_short Parkinson disease: Serotonin reuptake inhibitors for depression in PD
title_full Parkinson disease: Serotonin reuptake inhibitors for depression in PD
title_fullStr Parkinson disease: Serotonin reuptake inhibitors for depression in PD
title_full_unstemmed Parkinson disease: Serotonin reuptake inhibitors for depression in PD
title_sort Parkinson disease: Serotonin reuptake inhibitors for depression in PD
dc.creator.none.fl_str_mv Pérez Lloret, Santiago
Rascol, Olivier
author Pérez Lloret, Santiago
author_facet Pérez Lloret, Santiago
Rascol, Olivier
author_role author
author2 Rascol, Olivier
author2_role author
dc.subject.none.fl_str_mv enfermedad de parkinson
antidepresivos
depresión
topic enfermedad de parkinson
antidepresivos
depresión
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that these drugs are beneficial for the treatment of depressive disorders in Parkinson disease. Whether these treatments will offer such benefits in the long term compared with other pharmacological and nonpharmacological approaches remains to be determined.
Fil: Pérez Lloret, Santiago. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University of Toulouse; Francia
Fil: Rascol, Olivier. University of Toulouse; Francia
description A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that these drugs are beneficial for the treatment of depressive disorders in Parkinson disease. Whether these treatments will offer such benefits in the long term compared with other pharmacological and nonpharmacological approaches remains to be determined.
publishDate 2012
dc.date.none.fl_str_mv 2012-07
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/96182
Pérez Lloret, Santiago; Rascol, Olivier; Parkinson disease: Serotonin reuptake inhibitors for depression in PD; Nature Publishing Group; Nature Reviews Neurology; 8; 7; 7-2012; 365-366
1759-4758
CONICET Digital
CONICET
url http://hdl.handle.net/11336/96182
identifier_str_mv Pérez Lloret, Santiago; Rascol, Olivier; Parkinson disease: Serotonin reuptake inhibitors for depression in PD; Nature Publishing Group; Nature Reviews Neurology; 8; 7; 7-2012; 365-366
1759-4758
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/nrneurol.2012.111
info:eu-repo/semantics/altIdentifier/doi/10.1038/nrneurol.2012.111
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269426490015744
score 13.13397

Publicaciones similares